Global Influenza Diagnostic Market
Healthcare Services

Global Influenza Diagnostic Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends

The Global Influenza Diagnostic Market Report by The Business Research Company covers influenza diagnostic market drivers and restraints, influenza diagnostic market size, major players, and the impact of COVID-19 on the influenza diagnostic market.

The influenza diagnostic market consists of sales of diagnostic tests used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting the diagnostics tests for influenza virus detection.

The major factor driving the market is increasing funding for research on influenza diagnostics. Addressing the public health impact of influenza disease requires a proper understanding of the virus and its effect on individuals and populations.

The global influenza diagnostic market is expected to grow from $1.31 billion in 2020 to $1.33 billion in 2021 at a compound annual growth rate (CAGR) of 1.5%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The influenza diagnostic market is expected to reach $1.74 billion in 2025 at a CAGR of 7%.

 

Request A Sample For The Global Influenza Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

 

Some influenza diagnostic market trends include rapid influenza diagnostic tests (RIDTs). Rapid influenza diagnostic tests are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

Global influenza diagnostic market segments include:

1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic tests (RIDT), Viral Culture, DFA, Serological Assays, Others.

2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests.

3) By End User: Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users.

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

 

Read More On The Influenza Diagnostic Global Market Report 2021: COVID-19 Implications And Growth To 2030 At:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-market-global-report-2020-30-covid-19-implications-and-growth

 

The Influenza Diagnostic Global Market Report 2021: COVID-19 Implications And Growth To 2030 is one of a series of new reports from The Business Research Company that provides influenza diagnostic market overviews, analyzes and forecasts market size, share, influenza diagnostic market players, influenza diagnostic market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The influenza diagnostic market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

 

Where To Learn More:

Read Influenza Diagnostic Global Market Report 2021: COVID-19 Implications And Growth To 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.

Market Players Covered: F. Hoffmann-La Roche Ltd, Quidel Corporation, Тhеrmо Fіѕhеr, Abbott Laboratories, Hologic, Becton Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics, SA Scientific Ltd., Sekisui Diagnostics, bioMérieux Inc, Danaher Corporation, Siemens Healthineers, Coris Bioconcept Sprl, Mast Group, ELITech, Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics, Germaine Laboratories, Response Biomedical, TAUNS Laboratories, TRUPCR.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Influenza Diagnostic Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The Influenza Diagnostic Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

 

Here is a list of reports from The Business Research Company similar to the Influenza Diagnostic Global Market Report 2021:

Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030

Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth And Change To 2030

Telemedicine Services Global Market Report 2021: COVID-19 Growth And Change To 2030

Leave a Reply

Your email address will not be published. Required fields are marked *